Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Alzheimer'S Research & Therapy
|
August 5, 2010
The role of animal models in advancing amyloid-beta immunotherapy to the clinic
Dora Games, Peter Seubert
Current Opinion in Immunology
|
September 3, 2004
Current progress in beta-amyloid immunotherapy
Dale Schenk, Michael Hagen, Peter Seubert
Neuro-Degenerative Diseases
|
August 16, 2006
A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease
Dale B Schenk, Peter Seubert, Michael Grundman, et al.
Journal of Alzheimer'S Disease : JAD
|
August 18, 2006
Mice as models: transgenic approaches and Alzheimer's disease
Dora Games, Manuel Buttini, Dione Kobayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 16, 2005
Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activity
Nikolay L Malinin, Sarah Wright, Peter Seubert, et al.
Neuro-Degenerative Diseases
|
March 7, 2008
Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis
Michael Pride, Peter Seubert, Michael Grundman, et al.
Experimental Neurology
|
August 16, 2012
Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice
Frédérique Bard, Michael Fox, Stuart Friedrich, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 31, 2006
Distribution of Abeta peptide in whole blood
J Randall Slemmon, Cory L Painter, Sashi Nadanaciva, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 12, 2002
Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy
Brian J Bacskai, Stephen T Kajdasz, Megan E McLellan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 11, 2009
Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta
Kaoru Yamada, Chiori Yabuki, Peter Seubert, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Alzheimer'S Research & Therapy
|
August 5, 2010
The role of animal models in advancing amyloid-beta immunotherapy to the clinic
Dora Games, Peter Seubert
Current Opinion in Immunology
|
September 3, 2004
Current progress in beta-amyloid immunotherapy
Dale Schenk, Michael Hagen, Peter Seubert
Neuro-Degenerative Diseases
|
August 16, 2006
A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease
Dale B Schenk, Peter Seubert, Michael Grundman, et al.
Journal of Alzheimer'S Disease : JAD
|
August 18, 2006
Mice as models: transgenic approaches and Alzheimer's disease
Dora Games, Manuel Buttini, Dione Kobayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 16, 2005
Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activity
Nikolay L Malinin, Sarah Wright, Peter Seubert, et al.
Neuro-Degenerative Diseases
|
March 7, 2008
Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis
Michael Pride, Peter Seubert, Michael Grundman, et al.
Experimental Neurology
|
August 16, 2012
Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice
Frédérique Bard, Michael Fox, Stuart Friedrich, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 31, 2006
Distribution of Abeta peptide in whole blood
J Randall Slemmon, Cory L Painter, Sashi Nadanaciva, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 12, 2002
Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy
Brian J Bacskai, Stephen T Kajdasz, Megan E McLellan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 11, 2009
Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta
Kaoru Yamada, Chiori Yabuki, Peter Seubert, et al.
Page
of 4